Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ningyan Zhang
Trastuzumab-Doxorubicin Conjugate Provides Enhanced Anti-Cancer Potency and Reduced Cardiotoxicity
Journal of Cancer Therapy
Related publications
Trastuzumab-Related Cardiotoxicity in Early Breast Cancer: A Cohort Study
Oncologist
Cancer Research
Medicine
Oncology
An Engineered Bivalent Neuregulin Protects Against Doxorubicin-Induced Cardiotoxicity With Reduced Proneoplastic Potential
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Anthracycline- And Trastuzumab-Induced Cardiotoxicity: A Retrospective Study
Medical Oncology
Medicine
Cancer Research
Oncology
Hematology
Trastuzumab in the Treatment of Metastatic Breast Cancer : Anticancer Therapy Versus Cardiotoxicity
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Doxorubicin Cardiotoxicity and Target Cells: A Broader Perspective
Cardio-Oncology
A Meta-Analysis of Incidence and Risk Factors of Trastuzumab-Induced Cardiotoxicity in Breast Cancer
Journal of Patient-Centered Research and Reviews
Aptamer–drug Conjugate: Targeted Delivery of Doxorubicin in a HER3 Aptamer-Functionalized Liposomal Delivery System Reduces Cardiotoxicity
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Neuregulin1-ErbB Signaling in Doxorubicin-Induced Cardiotoxicity
Amelioration of Doxorubicin‑induced Cardiotoxicity by Resveratrol
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine